Jean‐Frédéric Blickle

1.2k total citations
46 papers, 783 citations indexed

About

Jean‐Frédéric Blickle is a scholar working on Pharmacology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jean‐Frédéric Blickle has authored 46 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 12 papers in Oncology and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jean‐Frédéric Blickle's work include Antibiotics Pharmacokinetics and Efficacy (13 papers), Drug Transport and Resistance Mechanisms (11 papers) and Folate and B Vitamins Research (8 papers). Jean‐Frédéric Blickle is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (13 papers), Drug Transport and Resistance Mechanisms (11 papers) and Folate and B Vitamins Research (8 papers). Jean‐Frédéric Blickle collaborates with scholars based in France and Luxembourg. Jean‐Frédéric Blickle's co-authors include Emmanuel Andrès, J.M. Brogard, S. Vinzio, Georges Kaltenbach, Esther Noël, Stéphane Affenberger, F. Jehl, H. Monteil, Jacques Zimmer and F. Maloisel and has published in prestigious journals such as The American Journal of Medicine, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Jean‐Frédéric Blickle

41 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Frédéric Blickle France 16 257 177 169 145 143 46 783
Damon Duquaine United States 11 57 0.2× 104 0.6× 217 1.3× 187 1.3× 216 1.5× 16 968
Vladimı́r Teplan Czechia 22 70 0.3× 86 0.5× 183 1.1× 200 1.4× 138 1.0× 85 1.5k
R. H. Girdwood United Kingdom 21 303 1.2× 144 0.8× 64 0.4× 225 1.6× 122 0.9× 77 1.2k
Han‐Hsiang Chen Taiwan 19 61 0.2× 53 0.3× 77 0.5× 226 1.6× 263 1.8× 57 1.1k
Beatriz Bayés Spain 17 78 0.3× 61 0.3× 141 0.8× 252 1.7× 80 0.6× 44 962
Heidi Grundt Norway 18 90 0.4× 92 0.5× 90 0.5× 129 0.9× 73 0.5× 46 792
José C. Divino Filho Sweden 17 157 0.6× 152 0.9× 69 0.4× 483 3.3× 119 0.8× 32 1.5k
Georgina Peñarroja Spain 10 73 0.3× 233 1.3× 64 0.4× 50 0.3× 63 0.4× 12 774
G.F. Batstone United Kingdom 15 61 0.2× 47 0.3× 98 0.6× 109 0.8× 104 0.7× 42 847
A C Kennedy United Kingdom 15 198 0.8× 93 0.5× 49 0.3× 188 1.3× 66 0.5× 47 845

Countries citing papers authored by Jean‐Frédéric Blickle

Since Specialization
Citations

This map shows the geographic impact of Jean‐Frédéric Blickle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Frédéric Blickle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Frédéric Blickle more than expected).

Fields of papers citing papers by Jean‐Frédéric Blickle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Frédéric Blickle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Frédéric Blickle. The network helps show where Jean‐Frédéric Blickle may publish in the future.

Co-authorship network of co-authors of Jean‐Frédéric Blickle

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Frédéric Blickle. A scholar is included among the top collaborators of Jean‐Frédéric Blickle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Frédéric Blickle. Jean‐Frédéric Blickle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dejager, S., Alfred Penfornis, Jean‐Frédéric Blickle, B. Fiquet, & Stéphane Quéré. (2014). How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study. Vascular Health and Risk Management. 10. 341–341. 27 indexed citations
2.
Bénétos, Athanase, Jean‐Luc Novella, Bruno Guerci, et al.. (2013). Pragmatic Diabetes Management in Nursing Homes: Individual Care Plan. Journal of the American Medical Directors Association. 14(11). 791–800. 18 indexed citations
3.
Halimi, S., et al.. (2012). Therapeutic management of orally treated type 2 diabetic patients, by French general practitioners in 2010: the DIAttitude Study. Diabetes & Metabolism. 38. S36–S46. 8 indexed citations
4.
Virally, Marie, Jean‐Frédéric Blickle, J. Girard, et al.. (2007). Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives. Diabetes & Metabolism. 33(4). 231–244. 85 indexed citations
5.
Andrès, Emmanuel, Stéphane Affenberger, Jacques Zimmer, et al.. (2006). Current hematological findings in cobalamin deficiency. A study of 201 consecutive patients with documented cobalamin deficiency. Clinical & Laboratory Haematology. 28(1). 50–56. 130 indexed citations
6.
Andrès, Emmanuel, Stéphane Affenberger, S. Vinzio, et al.. (2005). Food-cobalamin malabsorption in elderly patients: Clinical manifestations and treatment. The American Journal of Medicine. 118(10). 1154–1159. 99 indexed citations
7.
Noël, Esther, et al.. (2005). Paralysie faciale récidivante, syndrome de Gougerot-Sjögren primitif et carence en vitamine B12. La Presse Médicale. 34(2). 107–108. 5 indexed citations
8.
Andrès, Emmanuel, Noureddine Loukili, Esther Noël, et al.. (2005). Effects of oral crystalline cyanocobalamin 1000 μg/d in the treatment of pernicious anemia: An open-label, prospective study in Ten Patients. Current Therapeutic Research. 66(1). 13–22. 38 indexed citations
9.
Andrès, Emmanuel, et al.. (2004). Existe-t-il un lien entre les non-dissociations de la vitamine B12 et la maladie de biermer ?. Annales d Endocrinologie. 65(2). 118–120. 3 indexed citations
10.
Blickle, Jean‐Frédéric. (2004). Place des thiazolidinediones dans le traitement du diabète de type 2. La Presse Médicale. 33(15). 1034–1040. 6 indexed citations
11.
Zimmer, Jacques, et al.. (2004). Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center1. Clinical & Laboratory Haematology. 26(2). 137–142. 28 indexed citations
12.
Andrès, Emmanuel, Esther Noël, Anne Perrin, et al.. (2003). Efficacy of short-term oral cobalamin therapy for the treatment of cobalamin deficiencies related to food-cobalamin malabsorption: A study of 30 patients. Clinical & Laboratory Haematology. 25(3). 161–166. 50 indexed citations
13.
Andrès, Emmanuel, Esther Noël, Georges Kaltenbach, et al.. (2003). Carences en vitamine B12 avec test de Schilling normal ou syndrome de non-dissociation de la vitamine B12 de ses protéines porteuses chez le sujet âgé. Étude de 60 patients. La Revue de Médecine Interne. 24(4). 218–223. 19 indexed citations
14.
Andrès, Emmanuel, Georges Kaltenbach, Esther Noël, et al.. (2002). Données récentes sur le mode de présentation, de diagnostic et sur le traitement des maladies de Biermer en médecine interne : À propos d'une étude de 22 patients. La Revue de Médecine Interne. 23. 125s–126s. 1 indexed citations
15.
Brogard, J.M., et al.. (1994). Biliary elimination and hepatic disposition of an association of piperacillin and tazobactam: experimental evaluation.. PubMed. 20(6). 247–55. 5 indexed citations
16.
Brogard, J.M., et al.. (1989). Clinical Pharmacokinetics of Cefotiam. Clinical Pharmacokinetics. 17(3). 163–174. 15 indexed citations
17.
Briel, D. De, et al.. (1988). Endocardite a Corynebacterium du groupe D2, a point de depart urinaire. Médecine et Maladies Infectieuses. 18(5). 293–295. 19 indexed citations
18.
Brogard, J.M., F. Jehl, M Adloff, Jean‐Frédéric Blickle, & H. Monteil. (1988). High hepatic excretion in humans of cefpiramide, a new cephalosporin. Antimicrobial Agents and Chemotherapy. 32(9). 1360–1364. 9 indexed citations
19.
Brogard, J.M., et al.. (1988). [The role of ciprofloxacine metabolites in its biliary and urinary elimination in man].. PubMed. 36(5 Pt 2). 719–23. 3 indexed citations
20.
Brogard, J.M., et al.. (1986). Biliary Elimination of Cefotiam, an Experimental and Clinical Study. Chemotherapy. 32(3). 222–235. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Damon Duquaine Breakdown of academic impact, for papers by Vladimı́r Teplan Breakdown of academic impact, for papers by R. H. Girdwood Breakdown of academic impact, for papers by Han‐Hsiang Chen Breakdown of academic impact, for papers by Beatriz Bayés Breakdown of academic impact, for papers by Heidi Grundt Breakdown of academic impact, for papers by José C. Divino Filho Breakdown of academic impact, for papers by Georgina Peñarroja Breakdown of academic impact, for papers by G.F. Batstone Breakdown of academic impact, for papers by A C Kennedy
Rankless by CCL
2026